RLISX
Price
$21.95
Change
+$0.33 (+1.53%)
Updated
Apr 11 closing price
Net Assets
148.01M
VIVAX
Price
$63.21
Change
+$0.94 (+1.51%)
Updated
Apr 11 closing price
Net Assets
190.51B
Ad is loading...

RLISX vs VIVAX

Header iconRLISX vs VIVAX Comparison
Open Charts RLISX vs VIVAXBanner chart's image
Russell Inv Equity Income S
Price$21.95
Change+$0.33 (+1.53%)
VolumeN/A
Net Assets148.01M
Vanguard Value Index I
Price$63.21
Change+$0.94 (+1.51%)
VolumeN/A
Net Assets190.51B
RLISX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLISX vs. VIVAX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLISX is a Hold and VIVAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. RLISX (148M). VIVAX pays higher dividends than RLISX: VIVAX (2.14) vs RLISX (1.87). RLISX was incepted earlier than VIVAX: RLISX (17 years) vs VIVAX (32 years). RLISX (0.95) is less costly to investors than VIVAX (0.17). RLISX is a more actively managed with annual turnover of: 35.00 vs. VIVAX (10.00). RLISX has a lower initial minimum investment than VIVAX: RLISX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 0.72 vs. RLISX (-11.71). VIVAX return over 5 years is better than : 64.30 vs. RLISX (7.04).
RLISXVIVAXRLISX / VIVAX
Total Expense Ratio0.830.17488%
Annual Report Gross Expense Ratio0.950.17559%
Fund Existence17 years32 years-
Gain YTD-5.460-5.71296%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets148M191B0%
Annual Yield % from dividends1.872.1487%
Returns for 1 year-11.710.72-1,634%
Returns for 3 years-26.098.14-321%
Returns for 5 years7.0464.3011%
Returns for 10 years-40.7988.68-46%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.440.02
+5.69%
Lyell Immunopharma
CPRX22.050.60
+2.80%
Catalyst Pharmaceuticals
INNV2.820.06
+2.17%
InnovAge Holding Corp
UHAL61.040.18
+0.30%
U-Haul Holding Company
NLSP1.35N/A
-0.01%
Nls Pharmaceutics Ltd